neurizon ApS — Credit Rating and Financial Key Figures
CVR number: 36889845
Søtoften 43, 8250 Egå
neurologic@dadlnet.dk
tel: 29161929
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | 37.28 | 111.62 | |||
| Gross profit | 32.38 | 107.24 | -31.55 | -6.64 | -1.49 |
| Costs of management | -4.90 | -4.38 | |||
| EBIT | 32.38 | 107.24 | -31.55 | -6.64 | -1.49 |
| Other financial expenses | 4.23 | 3.08 | |||
| Net income from associates (fin.) | -0.02 | ||||
| Pre-tax profit | 32.38 | 107.24 | -31.55 | 2.41 | 1.57 |
| Net earnings | 32.38 | 107.24 | -31.55 | 2.41 | 1.57 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Investments total | |||||
| Long term receivables total | |||||
| Inventories total | |||||
| Short term receivables total | |||||
| Cash and bank deposits | 55.41 | 162.65 | 124.39 | 97.17 | 93.50 |
| Cash and cash equivalents | 55.41 | 162.65 | 124.39 | 97.17 | 93.50 |
| Balance sheet total (assets) | 55.41 | 162.65 | 124.39 | 97.17 | 93.50 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 51.00 | 51.00 | 51.00 | 51.00 | 51.00 |
| Shares repurchased | 2.41 | 1.57 | |||
| Other reserves | 0.03 | 100.21 | 37.12 | 39.42 | |
| Retained earnings | -27.97 | 4.38 | 4.73 | 4.23 | -0.06 |
| Profit of the financial year | 32.38 | 107.24 | -31.55 | 2.41 | 1.57 |
| Shareholders equity total | 55.41 | 162.65 | 124.39 | 97.17 | 93.50 |
| Non-current liabilities total | |||||
| Current liabilities total | |||||
| Balance sheet total (liabilities) | 55.41 | 162.65 | 124.39 | 97.17 | 93.50 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.